BMC Cardiovascular Disorders (Aug 2023)

Transapical transcatheter mitral valve implantation with J-valve in patients with degenerated mitral bioprostheses

  • Fan He,
  • Jianmao Hong,
  • Bijun Xu,
  • Shiqiang Wang,
  • Huaidong Chen,
  • Ximing Qian

DOI
https://doi.org/10.1186/s12872-023-03414-5
Journal volume & issue
Vol. 23, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Background Due to the widespread application of bioprosthetic valve in the treatment of mitral valve disease in recent years, the incidence of valve failure has increased significantly, which is facing the need of reoperation. For high-risk patients, transcatheter mitral valve-in-valve placement is increasingly being used as an alternative to surgical reoperation. Case presentation Here we report the successful transapical transcatheter mitral valve-in-valve implantations of J-Valves in 3 patients with high risk of mitral bioprostheses failure. All patients were discharged successfully, and the follow-up results were good 30 days after operation without major complication. Conclusions For high-risk patients, transcatheter implantation of the J-valve is a feasible solution for the treatment of degenerated mitral bioprostheses.

Keywords